누드마우스에 이종이식된 인형 구강편평세포암에서 방사선치료와선택적 Cyclooxygenase-2 억제제 병합치료의 효과
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김준희 | - |
dc.contributor.author | 박성윤 | - |
dc.contributor.author | 김희종 | - |
dc.contributor.author | 김기범 | - |
dc.contributor.author | 양훈식 | - |
dc.contributor.author | 이규석 | - |
dc.contributor.author | 이호진 | - |
dc.contributor.author | 지영훈 | - |
dc.date.available | 2019-07-18T03:57:28Z | - |
dc.date.issued | 2006 | - |
dc.identifier.issn | 2092-5859 | - |
dc.identifier.issn | 2092-6529 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/29177 | - |
dc.format.extent | 6 | - |
dc.publisher | 대한이비인후과학회 | - |
dc.title | 누드마우스에 이종이식된 인형 구강편평세포암에서 방사선치료와선택적 Cyclooxygenase-2 억제제 병합치료의 효과 | - |
dc.title.alternative | The Effect of Combination Therapy with Radiation and Selective Cyclooxygenase-2Inhibitor on Xenografted Human Oral Cavity Squamous Cell Carcinoma in Nude Mice | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | 대한이비인후과학회지 두경부외과학, v.49, no.4, pp 420 - 425 | - |
dc.identifier.kciid | ART001110757 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 425 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 420 | - |
dc.citation.title | 대한이비인후과학회지 두경부외과학 | - |
dc.citation.volume | 49 | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Radiation therapy·Cyclooxygenase 2 inhibitors·Squamous cell carcinoma·Radiation sensitizing agents. | - |
dc.subject.keywordAuthor | 방사선치료·COX-2억제제·편평상피세포암·방사선 감수성 증강제. | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.